A large number of drugs are transferred out of medical insurance (list attached)

For these local medical insurance products, the green channel of the national medical insurance catalogue has been closed, and relevant enterprises must respond in a timely manner

1, a large batch of drugs, Medicare will be called up

On June 24, the Hunan Provincial Medical Security Bureau issued a public announcement on the list of digestive drugs in Hunan Province in 2021

According to the document, in accordance with the provisions of the "Interim Measures for the Administration of Drugs for Basic Medical Insurance" (Order No.

After combing, Cyberlan found that many of the medicines during the digestion period in Hunan Province were commonly used drugs, including colloidal pectin bismuth, rosatidine acetate, rabeprazole, aprepitant, and leucin A , Compound diisopropylamine dichloroacetate, sodium phosphate, live Clostridium butyricum, vitamin D, lysine zinc gluconate, calcium zinc gluconate, calcium zinc gluconate, iron protein succinate, multidimensional iron, polygelatin peptide, asparagus Western medicine such as potassium phosphate, alanyl glutamine amino acid (18), nicorandil, compound tripeptide, recombinant human interferon a2b, nifuratel nystatin, amoxicillin, clavulanic acid, dezocine, etc.

At the same time, there are also Shensu Oral Liquid, Qingre Xiaoyanning Tablets, Yankening Pills, Pudilan Anti-inflammatory Oral Liquid, Aqi Ganxian Granules, Xiaoer Fupi Granules, Yinhuang Qingfei Capsules, Yinhuang Qingfei Capsules, Twenty proprietary Chinese medicines including Jinying Capsules will temporarily retain their medical insurance status

Coincidentally, on June 22, the Tianjin Municipal Medical Security Bureau issued a notice on the announcement of the second batch of excluded varieties in the Tianjin supplementary drug list

In accordance with the spirit of the document, in order to complete the three-year digestion of the non-national medical insurance drug list in the current drug catalog in Tianjin, after combing and comparing the occurrence of drug medical insurance costs and drug purchases, the second batch of excluded items was formulated and released, including a total of 155 Varieties

The document clarifies that the second batch of excluded products will withdraw from Tianjin’s basic medical insurance, work-related injury insurance and maternity insurance payment scope from July 1, 2021.

The remaining varieties will withdraw from the payment scope of our city’s basic medical insurance, work-related injury insurance and maternity insurance from July 1, 2022, and no further notice will be issued.

In the list of 155 excluded varieties, there are western medicines such as compound electrolyte glucose, potassium aspartate, glucose sodium potassium chloride, bismuth subsalicylate, azithromycin monobasic sodium phosphate, etc.

2.

In accordance with the previous requirements, the timetable for the transfer of local supplementary varieties out of medical insurance is as follows: 1.

The key points of a circulated medical insurance work are clear, and the dynamic adjustment of the 2021 drug catalog will be carried out

Correspondence of provinces across the country is no longer uncommon, and different provinces have different time nodes according to different arrangements

According to the schedule, the end of June 2021 will be the time for some provinces to confirm the second batch of local medical insurance clearance.

3.
The window of local medical insurance products is closed

On the evening of June 9, the National Medical Insurance Administration’s official website released the "Work Plan for the 2021 National Medical Insurance Drug Catalogue Adjustment" and the "Guidelines for the 2021 National Medical Insurance Drug Catalogue Adjustment Application Guidelines" for solicitation of comments, and the status of the 6th round of medical insurance negotiations.
And scope
.

It is worth noting that in last year’s plan: if the drugs entered into the latest provincial-level basic medical insurance drug list before December 31, 2019, they can also be included in the national medical insurance list to be added to the drug-this One rule did not appear in this year's medical insurance catalog adjustment plan
.

In fact, when the rules were released last year, some people in the industry believed that last year might be the last opportunity for local medical insurance products to enter
.
According to a report from Caijing.
com, there were basically no cases of successful transformation of local medical insurance last year, and the more reason lies in the product itself
.

According to Xiong Xianjun, Director of the Department of Medicine of the National Medical Insurance Administration, previously stated: (5 provinces shared) the establishment mainly considers that some provincial supplements may also have good clinical value and meet the criteria for inclusion in the medical insurance catalog
.
Including it will help to ensure the continuity and stability of medications for relevant patient groups, and reduce the pressure on the provinces to digest and supplement varieties
.

However, judging from the latest adjustment plan this year, the green channel for local medical insurance products to be eliminated has been closed.
For a large number of medical insurance products to be eliminated, the corresponding companies must either adjust their product layout or seek breakthroughs in the self-paid market, and they must respond.

.

Attached are the adjustments of each province:

Hunan digestion period retention catalog

Tianjin City

Yunnan

On July 1, 2020, the Yunnan Medical Insurance Bureau issued the "Drug Digestion Adjustment Plan beyond the Scope of the National Medical Insurance Drug List in Yunnan Province"
.

In the second year, there are 340 digestive drugs, accounting for 40.
621% of digestion, and medical insurance reimbursement is as of 24:00 on June 30, 2021; in the third year, there are 162 digestive drugs, accounting for 19.
355%, and medical insurance reimbursement is as of June 30, 2022.
24 o'clock on the day
.

Sichuan Province

Ninety-four drugs including Dumiphene lozenge will be released from the "Drug List" on August 1, 2020
.
44 kinds of drugs including Al-Mg Piline (II) will be released from the "Drug List" on August 1, 2021
.
It was also added that in order to ensure the continuity of medication for the insured persons, the two drugs, compound sodium acetate Ringer injection and compound lidocaine injection, will not be released temporarily
.